“The New 3M will remain a leading global material science innovator serving customers across a range of industrial and consumer end markets, and Health Care will be a leading global diversified healthcare technology company focused on wound care, healthcare IT, oral care and biopharma filtration,” the conglomerate said in a July 26 news release.
In 2021, New 3M brought in $26.8 billion in sales, and Health Care collected $8.6 billion, according to 3M.
The transaction is pending approval from the company’s board of directors, the IRS and the Securities and Exchange Commission.
